NM_000844.4:c.519+18164C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000844.4(GRM7):​c.519+18164C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.106 in 152,158 control chromosomes in the GnomAD database, including 879 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.11 ( 879 hom., cov: 32)

Consequence

GRM7
NM_000844.4 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.327

Publications

6 publications found
Variant links:
Genes affected
GRM7 (HGNC:4599): (glutamate metabotropic receptor 7) L-glutamate is the major excitatory neurotransmitter in the central nervous system, and it activates both ionotropic and metabotropic glutamate receptors. Glutamatergic neurotransmission is involved in most aspects of normal brain function and can be perturbed in many neuropathologic conditions. The metabotropic glutamate receptors are a family of G protein-coupled receptors that have been divided into three groups on the basis of sequence homology, putative signal transduction mechanisms, and pharmacologic properties. Group I includes GRM1 and GRM5, and these receptors have been shown to activate phospholipase C. Group II includes GRM2 and GRM3, while Group III includes GRM4, GRM6, GRM7 and GRM8. Group II and III receptors are linked to the inhibition of the cyclic AMP cascade but differ in their agonist selectivities. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2009]
GRM7 Gene-Disease associations (from GenCC):
  • neurodevelopmental disorder with seizures, hypotonia, and brain imaging abnormalities
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.121 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000844.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
NM_000844.4
MANE Select
c.519+18164C>T
intron
N/ANP_000835.1
GRM7
NM_181874.3
c.519+18164C>T
intron
N/ANP_870989.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GRM7
ENST00000357716.9
TSL:1 MANE Select
c.519+18164C>T
intron
N/AENSP00000350348.4
GRM7
ENST00000389336.8
TSL:1
c.519+18164C>T
intron
N/AENSP00000373987.4
GRM7
ENST00000389335.7
TSL:1
n.519+18164C>T
intron
N/AENSP00000373986.3

Frequencies

GnomAD3 genomes
AF:
0.106
AC:
16063
AN:
152038
Hom.:
877
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.112
Gnomad AMI
AF:
0.115
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.0741
Gnomad EAS
AF:
0.106
Gnomad SAS
AF:
0.0999
Gnomad FIN
AF:
0.0834
Gnomad MID
AF:
0.0949
Gnomad NFE
AF:
0.103
Gnomad OTH
AF:
0.0876
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.106
AC:
16083
AN:
152158
Hom.:
879
Cov.:
32
AF XY:
0.105
AC XY:
7781
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.112
AC:
4656
AN:
41522
American (AMR)
AF:
0.126
AC:
1920
AN:
15288
Ashkenazi Jewish (ASJ)
AF:
0.0741
AC:
257
AN:
3468
East Asian (EAS)
AF:
0.106
AC:
547
AN:
5154
South Asian (SAS)
AF:
0.0995
AC:
480
AN:
4822
European-Finnish (FIN)
AF:
0.0834
AC:
884
AN:
10594
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.103
AC:
7025
AN:
67992
Other (OTH)
AF:
0.0862
AC:
182
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
742
1484
2227
2969
3711
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
184
368
552
736
920
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.109
Hom.:
335
Bravo
AF:
0.110
Asia WGS
AF:
0.0980
AC:
341
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
4.0
DANN
Benign
0.66
PhyloP100
0.33
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs17031835; hg19: chr3-6921758; API